Shenzhen Salubris Pharmaceuticals News

Xinlitai: Announcement on action plans to double improve quality and return

Aug 31 00:00

Xinlitai: Announcement on obtaining exclusive licensing rights for the base-editing drug YOLT-101

Aug 27 00:00

Xinlitai: 2024 semi-annual financial report

Aug 27 00:00

Xinlitai: Half-year summary table of non-operating capital usage and other related capital transactions

Aug 27 00:00

Xinlitai: Announcement on Adjusting the Internal Investment Structure and Postponing of Some Fund-raising Projects

Aug 27 00:00

Shenzhen Salubris Pharmaceuticals: Announcement on the Progress of JK06 Overseas Clinical Trial

Aug 6 00:00

Shenzhen Salubris Pharmaceuticals: Announcement on the approval of clinical trial notification for new indications of Enadastron.

Aug 1 00:00

Shenzhen Salubris Pharmaceuticals: Announcement regarding the receipt of the clinical trial approval notice for SAL0120.

Jul 31 00:00

Shenzhen Salubris Pharmaceuticals: Announcement regarding the acceptance of the SAL056 listing application.

Jun 26 00:00

Shenzhen Salubris Pharmaceuticals: Asset management contract for Guolian Salubris No. 3 Employee Shareholding Single Asset Management Plan.

Jun 22 00:00

Shenzhen Salubris Pharmaceuticals: Announcement Regarding the Selection of the Management Committee for the Third Phase of Employee Stock Ownership Plan

Jun 21 00:00

Shenzhen Salubris Pharmaceuticals: Announcement on shareholders donating part of the company's shares free of charge

May 14 00:00

Xinlitai: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

Apr 23 00:00

Xinlitai: Legal Opinion of Beijing Jindu (Shenzhen) Law Firm on the 2023 Annual General Meeting of Shareholders of Shenzhen Xinlitai Pharmaceutical Co., Ltd.

Apr 23 00:00

Xinlitai: Announcement on capital increase for subsidiary Salubris Biotherapeutics, Inc.

Apr 23 00:00

Xinlitai: Announcement on JK07 obtaining a notice of approval for domestic clinical trials

Apr 8 00:00

Xinlitai: Report of the Board Audit Committee on the performance of supervisory duties by accountants in the 2023 annual audit

Mar 26 00:00

Xinlitai: Summary table on the use of non-operating capital and other related capital transactions in 2023

Mar 26 00:00

Xinlitai: Announcement on the use of its own idle funds to invest in wealth management products

Mar 26 00:00

Xinlitai: Notice of Annual General Meeting of Shareholders

Mar 26 00:00